How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

Abstract:

:There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has been recently strongly supported by the results of secondary prevention trials with PCSK9 inhibitors. The combination of PCSK9 inhibitors and statins has resulted in achieving extremely low LDL-C levels with additional reduction of CVD events in secondary prevention. However, despite large clinical benefits, the safety of aggressive LDL-C lowering should be always taken into consideration, and there is still an ongoing discussion on whether very low LDL-C might result in some non-CVD adverse events. However, based on the available knowledge, so far the serious adverse events associated with achieving of very low LDL-C levels or intensive drug therapy have not been noted. These positive clinical effects were reflected in current ESC/EAS Guidelines (2019) for dyslipidaemia management. The experts strongly recommended the LDL-C lowering to levels that have been achieved in trials of PCSK9 inhibitors. In this state of the art review, we aimed to finally justify the critical need for LDL-C reduction to very low levels in secondary prevention patients in order to be as low as possible, as early as possible, and preferably lifelong.

journal_name

Prog Cardiovasc Dis

authors

Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

doi

10.1016/j.pcad.2020.12.008

subject

Has Abstract

pub_date

2020-12-28 00:00:00

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(20)30210-3

pub_type

杂志文章,评审
  • The Current Global State of Key Lifestyle Characteristics: Health and Economic Implications.

    abstract::The chronic disease crisis we currently face must be addressed in rapid fashion. Cardiovascular (CV) and pulmonary diseases, diabetes as well as several forms of cancer are leading causes of morbidity and mortality globally. Collectively, these conditions have a significant impact on the quality of life of individuals...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.02.002

    authors: Arena R,McNeil A,Sagner M,Hills AP

    更新日期:2017-01-01 00:00:00

  • Initial Assessment and Triage of the Stroke Patient.

    abstract::Nearly 800,000 strokes occur in the United States each year, and stroke is the leading cause of preventable permanent disability. Timely recognition and treatment are imperative to reduce stroke-related morbidity and mortality. Given the evidence supporting intravenous thrombolysis and mechanical thrombectomy for isch...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.04.004

    authors: Zweifler RM

    更新日期:2017-01-01 00:00:00

  • Coronary angiography is the gold standard for patients with significant left ventricular dysfunction.

    abstract::Left ventricular (LV) dysfunction has been shown to be significantly related to ongoing myocardial ischemia, hibernation, and thus, coronary artery disease. Current treatments for patients with LV dysfunction and concomitant coronary artery disease center around the potential benefit of coronary revascularization, in ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.01.003

    authors: Lim MJ,White CJ

    更新日期:2013-03-01 00:00:00

  • Transcatheter therapy for tricuspid regurgitation: The surgical perspective.

    abstract::Tricuspid regurgitation (TR) remains a complex valve pathology affecting nearly two million people in the United States. Although it can present as a primary valve pathology, TR often presents as a late finding in patients with severe pulmonary disease or end-stage chronic heart failure. Surgical repair of isolated TR...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.11.016

    authors: Williams AM,Brescia AA,Watt TMF,Romano MA,Bolling SF

    更新日期:2019-01-01 00:00:00

  • Outcomes in Degenerative Mitral Regurgitation: Current State-of-the Art and Future Directions.

    abstract::Mitral regurgitation (MR) is the one of the most frequent valvular heart diseases in the developed world, often requiring surgical correction. Degenerative MR is the most common type of non-ischemic, organic MR in the western world. Since no medical treatment has been shown to be effective in preventing the consequenc...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.10.005

    authors: Desai MY,Grigioni F,Di Eusanio M,Saccocci M,Taramasso M,Maisano F,Suri RM,Gillinov AM

    更新日期:2017-01-01 00:00:00

  • The role of cardiovascular magnetic resonance in patients with acute coronary syndromes.

    abstract::Cardiovascular magnetic resonance (CMR) imaging is a recognized technique for characterization of myocardial tissue in stable ischemic heart disease. In addition, CMR is emerging as a noninvasive imaging tool that can provide supporting information to guide treatment in acute coronary syndromes (ACSs). The advantages ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.001

    authors: Dall Armellina E,Choudhury RP

    更新日期:2011-11-01 00:00:00

  • Myocardial perfusion imaging using contrast echocardiography.

    abstract::Microbubbles are an excellent intravascular tracer, and both the rate of myocardial opacification (analogous to coronary microvascular perfusion) and contrast intensity (analogous to myocardial blood volume) provide unique insights into myocardial perfusion. A strong evidence base has been accumulated to show comparab...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.03.005

    authors: Pathan F,Marwick TH

    更新日期:2015-05-01 00:00:00

  • Positron-emitting myocardial blood flow tracers and clinical potential.

    abstract::Positron-emitting myocardial flow radiotracers such as (15)O-water, (13)N-ammonia and (82)Rubidium in conjunction with positron-emission-tomography (PET) are increasingly applied in clinical routine for coronary artery disease (CAD) detection, yielding high diagnostic accuracy, while providing valuable information on ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.01.001

    authors: Schindler TH

    更新日期:2015-05-01 00:00:00

  • Noninvasive assessment of atherosclerosis.

    abstract::The application of ultrasound to clinical evaluation of the symptomatic patient requires less precision and accuracy than when it is used as an instrument to study atherogenesis. The clinician's goal is to locate hemodynamically significant lesions; studies of atherogenesis require auxometry (measurement of the growth...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/0033-0620(84)90007-0

    authors: Blankenhorn DH,Rooney JA,Curry PJ

    更新日期:1984-01-01 00:00:00

  • Secondary analysis of clinical trials--a cautionary note.

    abstract::There is concern in published reports and reviews that patients are being harmed or denied effective treatment by the use of questionable results from secondary analyses of data from clinical trials. A well-reported secondary analysis must make clear to the reader the uncertainty of the result--so clear, in fact, that...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.006

    authors: Marler JR

    更新日期:2012-01-01 00:00:00

  • Exercise blood pressure, cardiorespiratory fitness and mortality risk.

    abstract:OBJECTIVE:To assess the cardiorespiratory fitness (CRF) impact on the association between exercise blood pressure (BP) and mortality risk. PATIENTS AND METHODS:We assessed CRF in 15,004 US Veterans (mean age 57.5 ± 11.2 years) who completed a standardized treadmill test between January 1, 1988 and July 28, 2017 and ha...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2021.01.003

    authors: Kokkinos P,Faselis C,Sidossis L,Zhang J,Samuel IBH,Ahmed A,Karasik P,Pittaras A,Doumas M,Grassos C,Rosenberg S,Myers J

    更新日期:2021-01-26 00:00:00

  • Hypertrophic cardiomyopathy--therapy with slow channel inhibiting agents.

    abstract::Slow channel inhibiting agents, particularly verapamil, appear to produce beneficial effects in relieving symptoms of dyspnea, chest pain, and syncope or presyncope in over 70% of patients with hypertrophic cardiomyopathy. Symptomatic relief occurs in patients with and without left ventricular outflow obstruction. Exe...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(82)90016-0

    authors: Chatterjee K,Raff G,Anderson D,Parmley WW

    更新日期:1982-11-01 00:00:00

  • Obesity and Kidney Disease.

    abstract::Obesity is a systemic disease of the white adipose tissue, which has evolved into a global epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances, dysregulation of the energy-balance system, imbalances in metabolic homeostasis, a pro-inflammatory state and multiple target organ damages...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.005

    authors: Lakkis JI,Weir MR

    更新日期:2018-01-01 00:00:00

  • Comparative effects of lipid-lowering therapies.

    abstract::The pharmacologic regulation of lipid metabolism in patients with dyslipidemia is unequivocally associated with significant reductions in risk for cardiovascular morbidity and mortality. A number of therapeutic drug classes have been developed in an effort to ever more precisely and intensively modulate lipid metaboli...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2004.04.007

    authors: Davidson MH,Toth PP

    更新日期:2004-09-01 00:00:00

  • Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?

    abstract::Tumor necrosis factor alpha (TNF-alpha), a protein belonging to the family of cytokines, is one of the leading mediators of the immune response to inflammation. Its widespread biological effects are modulated by two circulating binding proteins corresponding to the extracellular domain of the membrane receptors, namel...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80028-5

    authors: Ceconi C,Curello S,Bachetti T,Corti A,Ferrari R

    更新日期:1998-07-01 00:00:00

  • Advanced Imaging Techniques for Mitral Regurgitation.

    abstract::Mitral regurgitation (MR) is one of the most commonly encountered valvular lesions in clinical practice. MR can be either primary (degenerative) or secondary (functional) depending on the etiology of MR and the pathology of the mitral valve (MV). Echocardiography is the primary diagnostic tool for MR and is key in det...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.10.001

    authors: Quien MM,Vainrib AF,Freedberg RS,Bamira DG,Benenstein RJ,Williams MR,Saric M

    更新日期:2018-01-01 00:00:00

  • Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.

    abstract::The role of antiarrhythmic agents in the post-MI patients has been investigated for several years. Recently, clinical trials have assessed the effects of amiodarone in the post-MI population. The Basel Antiarrhythmic Study of Infarct Survival (BASIS) trial showed a reduction in total mortality, sudden death, and life-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80023-6

    authors: Jafri SM,Borzak S,Goldberger J,Gheorghiade M

    更新日期:1998-07-01 00:00:00

  • Cardiac endothelium and tissue growth.

    abstract::In recent years, a number of peptide and nonpeptide signalling autacoids have been implicated in the regulation of cardiac myocyte growth as well as vasculogenesis and angiogenesis, and in the function of cardiac muscle following development. In this review, we first examine the evidence for a role for specific cytoki...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(97)80033-3

    authors: Balligand JL,Kelly RA,Smith TW

    更新日期:1997-01-01 00:00:00

  • Diagnosis and treatment of heart disease: are women different from men?

    abstract::Key questions concerning strategies for diagnosis, prevention, and treatment of heart disease in women remain unanswered. Thrombolytic therapy has been shown to reduce mortality similarly in men and women. In addition, percutaneous coronary intervention for acute coronary syndromes is as effective in women as in men. ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.07.004

    authors: Xhyheri B,Bugiardini R

    更新日期:2010-11-01 00:00:00

  • Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients.

    abstract::Pulmonary and/or tricuspid valve dysfunction is common among individuals with congenital heart disease, and surgical intervention often carries prohibitive risks. Transcatheter valve replacement (TVR) of the right-sided cardiac valves has become a viable treatment option over the past two decades, while continued tech...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.09.003

    authors: Gales J,Krasuski RA,Fleming GA

    更新日期:2018-01-01 00:00:00

  • Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

    abstract::Renal injury distal to an atherosclerotic renovascular obstruction reflects multiple intrinsic factors producing parenchymal tissue injury. Atherosclerotic disease pathways superimposed on renal arterial obstruction may aggravate damage to the kidney and other target organs, and some of the factors activated by renal ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2009.09.002

    authors: Lerman LO,Textor SC,Grande JP

    更新日期:2009-11-01 00:00:00

  • Aortic pain.

    abstract::With the exception of the pain of acute aortic dissection, the thoracic aorta is not usually considered as a pain-producing organ. However, nineteenth century clinicians considered the aorta as a source of cardiovascular pain in the presence of autopsy-documented inflammatory aortitis, aortic aneurysms, and arterial h...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80004-2

    authors: Wooley CF,Sparks EH,Boudoulas H

    更新日期:1998-05-01 00:00:00

  • Are the neuroprotective effects of exercise training systemically mediated?

    abstract::To date there is no cure available for dementia, and the field calls for novel therapeutic targets. A rapidly growing body of literature suggests that regular endurance training and high cardiorespiratory fitness attenuate cognitive impairment and reduce dementia risk. Such benefits have recently been linked to system...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.02.003

    authors: Tari AR,Norevik CS,Scrimgeour NR,Kobro-Flatmoen A,Storm-Mathisen J,Bergersen LH,Wrann CD,Selbæk G,Kivipelto M,Moreira JBN,Wisløff U

    更新日期:2019-01-01 00:00:00

  • Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?

    abstract::The first step in the diagnostic evaluation of patients with suspected syncope begins with an "initial evaluation" consisting of careful history taking, physical examination including orthostatic blood pressure measurement and electrocardiogram. However, even in expert centers the diagnostic yield of this "initial eva...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.11.002

    authors: Blanc JJ

    更新日期:2013-01-01 00:00:00

  • Air pollution and cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis.

    abstract::Research to date demonstrates a relationship between exposure to ambient air pollutants and cardiovascular disease (CVD). Many studies have shown associations between short-term exposures to elevated levels of air pollutants and CVD events, and several cohort studies suggest effects of long-term exposure on cardiovasc...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,多中心研究,评审

    doi:10.1016/j.pcad.2011.02.001

    authors: Gill EA,Curl CL,Adar SD,Allen RW,Auchincloss AH,O'Neill MS,Park SK,Van Hee VC,Diez Roux AV,Kaufman JD

    更新日期:2011-03-01 00:00:00

  • Ethics priorities in adult congenital heart disease.

    abstract::The success of modern therapies in congenital heart disease has produced a large and growing population of adults with congenital heart disease as a chronic condition. Such success increasingly raises a host of ethical issues, from resource utilization to end of life decision-making. The importance of a multidisciplin...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.10.004

    authors: Kirkpatrick JN,Kim YY,Kaufman BD

    更新日期:2012-11-01 00:00:00

  • Percutaneous Treatment for Native Mitral Regurgitation.

    abstract::Severe mitral regurgitation (MR) confers an adverse prognosis, frequently with debilitating symptoms of heart failure. While open surgical correction has been the standard of care for decades, novel catheter-based technologies have emerged that are highly effective in the treatment of MR. These percutaneous technologi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.11.003

    authors: Sorajja P,Maisano F

    更新日期:2017-01-01 00:00:00

  • Benefits of the Mediterranean Diet: Insights From the PREDIMED Study.

    abstract::The PREDIMED (PREvención con DIeta MEDiterránea) multicenter, randomized, primary prevention trial assessed the long-term effects of the Mediterranean diet (MeDiet) on clinical events of cardiovascular disease (CVD). We randomized 7447 men and women at high CVD risk into three diets: MeDiet supplemented with extra-vir...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.04.003

    authors: Martínez-González MA,Salas-Salvadó J,Estruch R,Corella D,Fitó M,Ros E,PREDIMED INVESTIGATORS.

    更新日期:2015-07-01 00:00:00

  • Transcatheter repair of tricuspid regurgitation with MitraClip.

    abstract::Transcatheter therapy with the MitraClip system (Abbott Structural, Menlo Park, CA) is the most commonly used transcatheter therapy for patients with tricuspid regurgitation, with over 1000 cases performed worldwide. The procedure is an off-label approach that requires meticulous attention to anatomical features obtai...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.10.001

    authors: Sorajja P,Cavalcante JL,Gossl M,Bae R

    更新日期:2019-01-01 00:00:00

  • Symptomatic Carotid Artery Disease: Revascularization.

    abstract::Patients with symptomatic carotid artery disease should be managed by a multidisciplinary team including neurologists, vascular surgeons and interventionalists. Duplex ultrasound is the most widely used diagnostic modality to assess carotid disease, followed by additional imaging tests (CT- or MR-angiography) to confi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.04.002

    authors: Montorsi P,Galli S,Ravagnani PM,Roffi M

    更新日期:2017-01-01 00:00:00